Artwork
iconShare
 
Manage episode 453482798 series 3297118
Content provided by Pam Didner and Camille Morhardt. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Pam Didner and Camille Morhardt or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

In this InTechnology episode, Camille Morhardt discusses the application of artificial intelligence (AI) in the biopharmaceutical and life sciences sectors with Prashant Shah, Intel's CTO for federated artificial intelligence products, and Abhishek Pandey, a global lead and principal research scientist at AbbVie. The conversation centers on the potential of AI, particularly federated learning, to revolutionize drug discovery and development. They explore the challenges of data privacy and IP protection in this context, emphasizing the importance of collaboration and the role of initiatives like OpenFL and MLCommons in setting standards for AI in the industry.

The views and opinions expressed are those of the guests and author and do not necessarily reflect the official policy or position of Intel Corporation.

  continue reading

100 episodes